Nomura Holdings Inc Vertex Pharmaceuticals Inc Transaction History

Nomura Holdings Inc

$70.8 Billion
Q4 2024

A detailed history of Nomura Holdings Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nomura Holdings Inc holds 45,901 shares of VRTX stock, worth $22.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

45,901

Previous 40,033 14.66%

Holding current value

$22.7 Million

Previous $18.6 Million 0.72%

% of portfolio

0.03%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $2.33 Million - $3.03 Million	5,868 Added 14.66%	45,901 $18.5 Million
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $16.4 Million - $18 Million	35,626 Added 808.4%	40,033 $18.6 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $152,803 - $188,871	-389 Reduced 8.11%	4,407 $2.07 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $1.96 Million - $2.14 Million	4,796 New	4,796 $2 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $3.08 Million - $3.68 Million	8,970 New	8,970 $3.65 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $365,984 - $409,623	1,164 New	1,164 $409,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $706,524 - $879,697	-3,007 Reduced 67.08%	1,476 $424,000
Q1 2022 May 18, 2022	SELL	$221.42 - $260.97 $2.35 Million - $2.77 Million	-10,618 Reduced 70.31%	4,483 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $56,643 - $71,504	-320 Reduced 2.08%	15,101 $3.32 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $222,928 - $249,474	-1,229 Reduced 7.38%	15,421 $2.78 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $2.89 Million - $3.41 Million	15,423 Added 1256.97%	16,650 $3.36 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $3.5 Million - $4.08 Million	-16,924 Reduced 93.24%	1,227 $264,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $3.6 Million - $4.8 Million	17,374 Added 2236.04%	18,151 $4.29 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $7.37 Million - $8.73 Million	-28,814 Reduced 97.37%	777 $212,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $11.5 Million - $15.1 Million	-51,197 Reduced 63.37%	29,591 $8.6 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $16.1 Million - $20 Million	80,788 New	80,788 $19.2 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $2.27 Million - $2.82 Million	-11,373 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $1.9 Million - $2.55 Million	11,373 New	11,373 $2.49 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $12.3 Million - $14.6 Million	-75,015 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $11.4 Million - $14.4 Million	75,015 New	75,015 $12.4 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $5.92 Million - $6.8 Million	-35,276 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $1.67 Million - $1.94 Million	11,436 Added 47.97%	35,276 $4.67 Million
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $12.9 Million - $15.1 Million	-85,280 Reduced 78.15%	23,840 $3.88 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $3.61 Million - $4.22 Million	23,840 Added 27.95%	109,120 $16.7 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $9.02 Million - $10.2 Million	65,730 Added 336.21%	85,280 $12.8 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $2.9 Million - $3.17 Million	19,550	19,550 $2.97 Million

Others Institutions Holding VRTX

# of Institutions

1,762

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $127B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Vertex Pharmaceuticals Inc Transaction History